ALLMedicine™ Secondary Polycythemia Center
Research & Reviews 51 results
https://emedicine.medscape.com/article/205039-clinical
Jun 7th, 2022 - History Patients with a high red blood cell mass usually have plethora or a ruddy complexion. However, if the polycythemia is secondary to hypoxia, as in venous-to-arterial shunts or compromised lung and oxygenation, patients can also appear cyano...
http://emedicine.medscape.com/article/205039-overview
Jun 7th, 2022 - Practice Essentials In secondary polycythemia, the number of red blood cells (RBCs) is increased as a result of an underlying condition. Secondary polycythemia would more accurately be called secondary erythrocytosis or erythrocythemia, as those t...
https://emedicine.medscape.com/article/205039-print
Jun 7th, 2022 - Practice Essentials In secondary polycythemia, the number of red blood cells (RBCs) is increased as a result of an underlying condition. Secondary polycythemia would more accurately be called secondary erythrocytosis or erythrocythemia, as those t...
https://emedicine.medscape.com/article/205039-workup
Jun 7th, 2022 - Laboratory Studies Testing for the JAK2 V617F mutation and an erythropoietin (EPO) level helps differentiate secondary polycythemia from polycythemia vera. [22, 23] Positive JAK2 V617F mutation status with a low EPO level confirms the diagnosis of...
https://emedicine.medscape.com/article/205039-treatment
Jun 7th, 2022 - Medical Care Correction of the underlying cause of secondary polycythemia is the most important element of managment. This may include cessation of exogenous erythropoietin, repair of shunts or removal of tumors that are secreting erythropoietin. ...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT03008642
Feb 4th, 2019 - The definition of a true polycythemia is stricto sensu an increased red cell mass (RCM) above 125% of the expected value depending on the size and the weight of the patient. However, this measurement requires an isotopic labeling of red cells and ...
News 3 results
https://www.onclive.com/view/expert-discusses-latest-developments-in-mpns
Nov 13th, 2020 - Rami S. Komrokji, MD Diagnostic and treatment advances have advanced the field of myeloproliferative neoplasms (MPNs) over the past several years, says Rami Komrokji, MD, who discussed MPNs at the 2017 OncLive® State of the Science Summit™. Komr...
https://www.medscape.com/viewarticle/950420
Abstract and Introduction Abstract Objectives: Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with diverse clinical, including hematologic, abnormalities. We describe periph...
https://www.medscape.com/viewarticle/555373_5
Conclusion In rare cases, hydronephrotic kidney disease can be the cause of erythropoietin-associated secondary polycythemia, even in nonfunctioning kidneys. CLICK HERE for subscription information about this journal.